Tissue World Magazine
Alexandra Stuthridge, Technical Business Manager, BioProducts Institute (BPI)

(News from RISI) – Kimberly-Clark (K-C) has announced its intention to invest in operations at its Millicent mill in South Australia, expanding its capacity.

It declined to reveal the new target capacity of the plant, which can presently manufacture about 100,000tpy of tissue.

Nor did it define the exact nature of the planned work, which is planned to roll out over the coming year at a cost of around A$20 million ($17.4 million).